164 related articles for article (PubMed ID: 33720400)
1. Transcription factor AP-2beta in development, differentiation and tumorigenesis.
Raap M; Gierendt L; Kreipe HH; Christgen M
Int J Cancer; 2021 Sep; 149(6):1221-1227. PubMed ID: 33720400
[TBL] [Abstract][Full Text] [Related]
2. Char Syndrome a novel mutation and new insights: A clinical report.
Massaad E; Tfayli H; Awwad J; Nabulsi M; Farra C
Eur J Med Genet; 2019 Dec; 62(12):103607. PubMed ID: 30579973
[TBL] [Abstract][Full Text] [Related]
3. Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.
Raap M; Gronewold M; Christgen H; Glage S; Bentires-Alj M; Koren S; Derksen PW; Boelens M; Jonkers J; Lehmann U; Feuerhake F; Kuehnle E; Gluz O; Kates R; Nitz U; Harbeck N; Kreipe HH; Christgen M
Lab Invest; 2018 Jan; 98(1):117-129. PubMed ID: 29035379
[TBL] [Abstract][Full Text] [Related]
4. A novel missense mutation in TFAP2B associated with Char syndrome and central diabetes insipidus.
Edward HL; D'Gama AM; Wojcik MH; Brownstein CA; Kenna MA; Grant PE; Majzoub JA; Agrawal PB
Am J Med Genet A; 2019 Jul; 179(7):1299-1303. PubMed ID: 31012281
[TBL] [Abstract][Full Text] [Related]
5. [Research progress of genetic research on Char syndrome].
Zhao M; Fan L; Xiang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jun; 41(6):758-760. PubMed ID: 38818565
[TBL] [Abstract][Full Text] [Related]
6. AP-2β is a transcriptional regulator for determination of digit length in tetrapods.
Seki R; Kitajima K; Matsubara H; Suzuki T; Saito D; Yokoyama H; Tamura K
Dev Biol; 2015 Nov; 407(1):75-89. PubMed ID: 26277217
[TBL] [Abstract][Full Text] [Related]
7. Char syndrome, a familial form of patent ductus arteriosus, with a new finding: hypoplasia [corrected] of the 3rd finger.
Babaoğlu K; Oruç M; Günlemez A; Gelb BD
Anadolu Kardiyol Derg; 2012 Sep; 12(6):523-4. PubMed ID: 22728731
[No Abstract] [Full Text] [Related]
8. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus.
Satoda M; Zhao F; Diaz GA; Burn J; Goodship J; Davidson HR; Pierpont ME; Gelb BD
Nat Genet; 2000 May; 25(1):42-6. PubMed ID: 10802654
[TBL] [Abstract][Full Text] [Related]
9. The AP-2 Transcription Factor APTF-2 Is Required for Neuroblast and Epidermal Morphogenesis in Caenorhabditis elegans Embryogenesis.
Budirahardja Y; Tan PY; Doan T; Weisdepp P; Zaidel-Bar R
PLoS Genet; 2016 May; 12(5):e1006048. PubMed ID: 27176626
[TBL] [Abstract][Full Text] [Related]
10. A study of familial Char syndrome involving the TFAP2B gene with a focus on facial shape characteristics.
Nyboe D; Kreiborg S; Darvann T; Dunø M; Nissen KR; Hove HB
Clin Dysmorphol; 2018 Jul; 27(3):71-77. PubMed ID: 29683802
[TBL] [Abstract][Full Text] [Related]
11. Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.
Chen YW; Zhao W; Zhang ZF; Fu Q; Shen J; Zhang Z; Ji W; Wang J; Li F
Pediatr Cardiol; 2011 Oct; 32(7):958-65. PubMed ID: 21643846
[TBL] [Abstract][Full Text] [Related]
12. KCTD1 mutants in scalp‑ear‑nipple syndrome and AP‑2α P59A in Char syndrome reciprocally abrogate their interactions, but can regulate Wnt/β‑catenin signaling.
Hu L; Chen L; Yang L; Ye Z; Huang W; Li X; Liu Q; Qiu J; Ding X
Mol Med Rep; 2020 Nov; 22(5):3895-3903. PubMed ID: 33000225
[TBL] [Abstract][Full Text] [Related]
13. Characterization of transcription factor AP-2 β mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency.
Ji W; Benson MA; Bhattacharya S; Chen Y; Hu J; Li F
J Surg Res; 2014 May; 188(2):466-472. PubMed ID: 24507797
[TBL] [Abstract][Full Text] [Related]
14. Tfap2b mutation in mice results in patent ductus arteriosus and renal malformation.
Wang J; Ji W; Zhu D; Wang W; Chen Y; Zhang Z; Li F
J Surg Res; 2018 Jul; 227():178-185. PubMed ID: 29804851
[TBL] [Abstract][Full Text] [Related]
15. Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus.
Khetyar M; Syrris P; Tinworth L; Abushaban L; Carter N
Genet Test; 2008 Sep; 12(3):457-9. PubMed ID: 18752453
[TBL] [Abstract][Full Text] [Related]
16. TFAP2B mutation and dental anomalies.
Tanasubsinn N; Sittiwangkul R; Pongprot Y; Kawasaki K; Ohazama A; Sastraruji T; Kaewgahya M; Kantaputra PN
J Hum Genet; 2017 Aug; 62(8):769-775. PubMed ID: 28381879
[TBL] [Abstract][Full Text] [Related]
17. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.
Mani A; Radhakrishnan J; Farhi A; Carew KS; Warnes CA; Nelson-Williams C; Day RW; Pober B; State MW; Lifton RP
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2975-9. PubMed ID: 15684060
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are not associated with the incidence of patent ductus arteriosus in Japanese preterm infants.
Kawase K; Sugiura T; Nagaya Y; Yamada T; Sugimoto M; Ito K; Togawa T; Nagasaki R; Kato T; Kouwaki M; Koyama N; Saitoh S
Pediatr Int; 2016 Jun; 58(6):461-6. PubMed ID: 26615960
[TBL] [Abstract][Full Text] [Related]
19. Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation.
Zhao F; Weismann CG; Satoda M; Pierpont ME; Sweeney E; Thompson EM; Gelb BD
Am J Hum Genet; 2001 Oct; 69(4):695-703. PubMed ID: 11505339
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.
Raap M; Gierendt L; Werlein C; Kuehnle E; Kreipe HH; Christgen M
J Mol Histol; 2021 Dec; 52(6):1257-1264. PubMed ID: 34117603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
